Real-world adalimumab survival and discontinuation factors in hidradenitis suppurativa.

MLA

Garbayo-Salmons, Patricia, et al. “Real-World Adalimumab Survival and Discontinuation Factors in Hidradenitis Suppurativa.” Journal of the European Academy of Dermatology and Venereology : JEADV, Apr. 2024. EBSCOhost, https://doi.org/10.1111/jdv.20044.

APA

Garbayo-Salmons, P., Vilarrasa, E., Bassas-Vila, J., Mora-Fernández, V., Fuertes, I., Luque-Luna, M., Fornons-Servent, R., Martin-Ezquerra, G., Aguayo-Ortiz, R. S., Ceravalls, J., Mollet, J., Gómez Tomás, Á., Masferrer, E., Corral-Magaña, O., Matas-Nadal, C., Del Estal, J., Fuertes Bailón, D., Calvet, J., & Romaní, J. (2024). Real-world adalimumab survival and discontinuation factors in hidradenitis suppurativa. Journal of the European Academy of Dermatology and Venereology : JEADV. https://doi.org/10.1111/jdv.20044

Chicago

Garbayo-Salmons, Patricia, Eva Vilarrasa, Julio Bassas-Vila, Veronica Mora-Fernández, Irene Fuertes, Mar Luque-Luna, Rosa Fornons-Servent, et al. 2024. “Real-World Adalimumab Survival and Discontinuation Factors in Hidradenitis Suppurativa.” Journal of the European Academy of Dermatology and Venereology : JEADV, April. doi:10.1111/jdv.20044.